Providing quicker and more accurate newborn screening results.
Innovating to Make an Impact
PerkinElmer’s commitment to scientific innovation is at the heart of everything we do. It is why our customers turn to us to help them accelerate their science and why we continue to be at the helm of delivering the most advanced solutions, coupled with world-class knowledge and expertise, to make an impact. With our over 3,300 patents and counting, global network of R&D centers of excellence and market-leading detection, imaging, and informatics innovations, PerkinElmer provides an unmatched experience that enables customers to solve critical issues in human and environmental health.
Discover Our Innovations
Screening for unknown adulterants in milk powder to combat food fraud.
Enabling more predictive results earlier in the drug discovery process.
Accelerating sample analysis for faster decisions, from environmental monitoring to industrial testing.
Empowering high content data analysis in biological research and drug discovery, through Spotfire®.
Revolutionizing how students and researchers collect and share data in the cloud.
i2i is PerkinElmer’s process for turning knowledge into action for a better world. It is our proprietary and collaborative business approach to innovation, using customer insights to develop and deliver the right solutions to help solve customers’ most critical business and scientific goals.
How Does i2i Work?
Through active listening to and collaboration with our customers, we gather in-depth insights into their needs and the problems they are trying to solve. Within PerkinElmer, we share those insights and work across the organization to determine new solutions and approaches. We then translate ideas and concepts into new, differentiated offerings that solve challenges and deliver better outcomes.